A Phase I Study combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, with Ipilimumab to Treat high-risk Renal Cell Carcinoma

NOT ENROLLING

Trial ID:

NCT02950766

Protocol # :

16-097

Phase

I

Disease Sites

Kidney

Principal Investigator

Choueiri, Toni, K

Site Investigator

Harden, Maegan, V.

McDermott, David, F.

Ott, Patrick

Site Research Nurses

Appleby, Laurie

Baylies, Rosemarie

Caparrotta, Caryn, Marie

Carey, Margaret, M.

Combs, Sarah

Fidyk, Erin

Gillen Mckay, Christine, A.

Grimes, Hayley

Hart, Kayla

Hercule, Sergina

Kelley, Kristina

Mackoul, Anna

Maurer, Kimberly

O’Neill, Kailene

Rang, Bethany

Rowan, Jennifer, M.

Stocker, Doris, Layon

Treveloni, Emily

Trial Description

Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #16-097

16-097